Table 2.
Adverse reactions after either dose of SARS-CoV-2 vaccines
| Characteristics | C-cirrhosis (n = 388) | D-cirrhosis (n = 165) | p value |
|---|---|---|---|
| Local adverse reactions | |||
| Any | 29 (7.47) | 11 (6.67) | 0.737 |
| Pain | 0.316 | ||
| Grade 1 | 23 (5.93) | 8 (4.85) | |
| Grade 2 | 0 (0) | 1 (0.61) | |
| Induration | 0.999 | ||
| Grade 1 | 1 (0.26) | 0 (0) | |
| Erythema | 0.508 | ||
| Grade 1 | 1 (0.26) | 1 (0.61) | |
| Swelling | 0.329 | ||
| Grade 1 | 5 (1.29) | 0 (0) | |
| Pruritus | 0.298 | ||
| Grade 1 | 0 (0) | 1 (0.61) | |
| Systematic adverse events | |||
| Any | 19 (4.9) | 11 (6.67) | 0.401 |
| Fatigue | 0.442 | ||
| Grade 1 | 5 (1.29) | 2 (1.21) | |
| Grade 2 | 0 (0) | 1 (0.61) | |
| Vertigo | 0.332 | ||
| Grade 1 | 5 (1.29) | 1 (0.61) | |
| Somnolence | 0.732 | ||
| Grade 1 | 4 (1.0) | 2 (1.21) | |
| Grade 2 | 0 (0) | 1 (0.61) | |
| Nausea | 0.586 | ||
| Grade 1 | 2 (0.52) | 2 (1.21) | |
| Fever | 0.113 | ||
| Grade 1 | 2 (0.52) | 1 (0.61) | |
| Ventosity | 0.089 | ||
| Grade 2 | 0 (0) | 2 (1.21) | |
| Diarrhea | 0.508 | ||
| Grade 1 | 1 (0.26) | 1 (0.61) | |
| Edema of lower limbs | 0.508 | ||
| Grade 1 | 1 (0.26) | 1 (0.61) | |
| Cough | 0.508 | ||
| Grade 1 | 1 (0.26) | 1 (0.61) | |
| Arthralgia | 0.999 | ||
| Grade 1 | 1 (0.26) | 0 (0) | |
| Xerostomia | 0.298 | ||
| Grade 1 | 0 (0) | 1 (0.61) | |
| Albiduria | 1.000 | ||
| Grade 1 | 1 (0.26) | 0 (0) | |
| Hearing loss | 1.000 | ||
| Grade 1 | 1 (0.26) | 0 (0) | |
| Myalgia | 0.298 | ||
| Grade 1 | 0 (0) | 1 (0.61) | |
| Anorexia | 0.089 | ||
| Grade 1 | 0 (0) | 1 (0.61) | |
| Grade 2 | 0 (0) | 1 (0.61) |
Data are displayed as n (%). C-cirrhosis, compensated cirrhosis; D-cirrhosis, decompensated cirrhosis